Methods for identifiying compounds for regulating cardiac dysfunction
CA 2449417 A1 · Owner: Doersen, Claus-Jens Walter · Inventors: Kawamoto, Richard Masaru; Doersen, Claus-Jens Walter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention identifies genes and proteins of the ubiquitinylation pathway in, humans and in various animal models whose expression patterns are altered when a heart tissue, develops cardiomyopathy. The genes identified may be used as markers for the disease onset and, progression. The present invention provides methods to screen agents that are capable of, modulating the progress of cardiomyopathy. The present invention also provides methods of, identifying therapeutic compounds that can treat various cardiomyopathies by analyzing the, expression of one or more of the genes and proteins identified.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 4, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 4, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 4, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.